van der Goot et al. [22] reported that knockdown of the gene tdo-2, encoding the kynurenine pathway enzyme tryptophan 2,3-dioxygenase (TDO), delayed the age-associated pathology in several of these models, including worms expressing human amyloid-beta (Aβ) or a 35-unit polyglutamine tract (Q35), modeling proteotoxicity in AD and HD, respectively. The gene discussed is TDO2; the disease is Huntington disease.